Optimizing MR-Guided Radiotherapy for Breast Cancer Patients

Current research in radiotherapy (RT) for breast cancer is evaluating neoadjuvant as opposed to adjuvant partial breast irradiation (PBI) with the aim of reducing the volume of breast tissue irradiated and therefore the risk of late treatment-related toxicity. The development of magnetic resonance (...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Oncol
Autori principali: Groot Koerkamp, Maureen L., Vasmel, Jeanine E., Russell, Nicola S., Shaitelman, Simona F., Anandadas, Carmel N., Currey, Adam, Vesprini, Danny, Keller, Brian M., De-Colle, Chiara, Han, Kathy, Braunstein, Lior Z., Mahmood, Faisal, Lorenzen, Ebbe L., Philippens, Marielle E. P., Verkooijen, Helena M., Lagendijk, Jan J. W., Houweling, Antonetta C., van den Bongard, H. J. G. Desiree, Kirby, Anna M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2020
Soggetti:
Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7399349/
https://ncbi.nlm.nih.gov/pubmed/32850318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01107
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi